FR2882552B1 - Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation - Google Patents

Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation

Info

Publication number
FR2882552B1
FR2882552B1 FR0501949A FR0501949A FR2882552B1 FR 2882552 B1 FR2882552 B1 FR 2882552B1 FR 0501949 A FR0501949 A FR 0501949A FR 0501949 A FR0501949 A FR 0501949A FR 2882552 B1 FR2882552 B1 FR 2882552B1
Authority
FR
France
Prior art keywords
metronidazole
processes
preparation
high stability
aqueous gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0501949A
Other languages
English (en)
Other versions
FR2882552A1 (fr
Inventor
Leila Zarif
Gerald Pedrassi
Alain Brzokewicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0501949A priority Critical patent/FR2882552B1/fr
Application filed by Galderma SA filed Critical Galderma SA
Priority to PT67074476T priority patent/PT1855650E/pt
Priority to ES06707447T priority patent/ES2400502T3/es
Priority to RU2007135364/15A priority patent/RU2409346C2/ru
Priority to EP06707447A priority patent/EP1855650B1/fr
Priority to DK06707447.6T priority patent/DK1855650T3/da
Priority to SI200631537T priority patent/SI1855650T1/sl
Priority to CA002598031A priority patent/CA2598031A1/fr
Priority to CNA2006800059009A priority patent/CN101128185A/zh
Priority to BRPI0608044-8A priority patent/BRPI0608044A2/pt
Priority to JP2007556571A priority patent/JP2008531517A/ja
Priority to KR1020077019197A priority patent/KR20070112139A/ko
Priority to MX2007010179A priority patent/MX2007010179A/es
Priority to PCT/EP2006/002074 priority patent/WO2006089804A1/fr
Priority to PL06707447T priority patent/PL1855650T3/pl
Priority to AU2006218043A priority patent/AU2006218043B2/en
Priority to AR20060100653A priority patent/AR054228A1/es
Publication of FR2882552A1 publication Critical patent/FR2882552A1/fr
Priority to US11/892,292 priority patent/US20090215849A1/en
Priority to ZA200707558A priority patent/ZA200707558B/xx
Publication of FR2882552B1 publication Critical patent/FR2882552B1/fr
Application granted granted Critical
Priority to CY20131100208T priority patent/CY1113783T1/el
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
FR0501949A 2005-02-25 2005-02-25 Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation Expired - Fee Related FR2882552B1 (fr)

Priority Applications (20)

Application Number Priority Date Filing Date Title
FR0501949A FR2882552B1 (fr) 2005-02-25 2005-02-25 Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation
MX2007010179A MX2007010179A (es) 2005-02-25 2006-02-16 Gel topico acuoso de alta estabilidad a base de metronidazol y metodo para su preparacion.
RU2007135364/15A RU2409346C2 (ru) 2005-02-25 2006-02-16 Водный гель для местного применения высокой стабильности на основе метронидазола и способ его получения
EP06707447A EP1855650B1 (fr) 2005-02-25 2006-02-16 Gel topique aqueux a stabilite elevee, a base de metronidazole, et procede de preparation
DK06707447.6T DK1855650T3 (da) 2005-02-25 2006-02-16 Vandig, topisk gel med høj stabilitet baseret på metronidazol og fremgangsmåde til fremstilling heraf
SI200631537T SI1855650T1 (sl) 2005-02-25 2006-02-16 Vodni topikalni gel z visoko stabilnostjo na osnovi metronidazola in postopek priprave
CA002598031A CA2598031A1 (fr) 2005-02-25 2006-02-16 Gel topique aqueux a stabilite elevee, a base de metronidazole, et procede de preparation
ES06707447T ES2400502T3 (es) 2005-02-25 2006-02-16 Gel tópico acuoso de alta estabilidad a base de metronidazol y método de preparación
BRPI0608044-8A BRPI0608044A2 (pt) 2005-02-25 2006-02-16 método para preparar um gel aquoso estável à base de metronidazol, composição e uso de uma composição
JP2007556571A JP2008531517A (ja) 2005-02-25 2006-02-16 メトロニダゾールに基づく高安定性の水性局所用ゲル、及び調製方法
PT67074476T PT1855650E (pt) 2005-02-25 2006-02-16 Gel tópico aquoso com elevada estabilidade baseado em metronidazol e método de preparação
KR1020077019197A KR20070112139A (ko) 2005-02-25 2006-02-16 메트로니다졸 기재의 고안정성 수성 외용 겔 및 제조 방법
AU2006218043A AU2006218043B2 (en) 2005-02-25 2006-02-16 Aqueous topical gel of high stability based on metronidazole and method of preparation
PL06707447T PL1855650T3 (pl) 2005-02-25 2006-02-16 Wodny miejscowy żel o wysokiej stabilności, oparty na metronidazolu, i sposób otrzymywania
PCT/EP2006/002074 WO2006089804A1 (fr) 2005-02-25 2006-02-16 Gel topique aqueux a stabilite elevee, a base de metronidazole, et procede de preparation
CNA2006800059009A CN101128185A (zh) 2005-02-25 2006-02-16 基于甲硝哒唑的高稳定性含水局部凝胶和制备方法
AR20060100653A AR054228A1 (es) 2005-02-25 2006-02-23 Geles acuosos de alta estabilidad a base de metronidazol y procedimiento para su preparacion
US11/892,292 US20090215849A1 (en) 2005-02-25 2007-08-21 High stability aqueous gels comprising metronidazole and methods for the preparation thereof
ZA200707558A ZA200707558B (en) 2005-02-25 2007-09-03 Aqueous topical gel of high stability based on metronidazole and method of preparation
CY20131100208T CY1113783T1 (el) 2005-02-25 2013-03-05 Υδατικη τοπικη γελη υψηλης σταθεροτητας με βαση την μετρονιδαζολη και μεθοδος παρασκευης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0501949A FR2882552B1 (fr) 2005-02-25 2005-02-25 Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation

Publications (2)

Publication Number Publication Date
FR2882552A1 FR2882552A1 (fr) 2006-09-01
FR2882552B1 true FR2882552B1 (fr) 2008-12-26

Family

ID=35044713

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0501949A Expired - Fee Related FR2882552B1 (fr) 2005-02-25 2005-02-25 Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation

Country Status (19)

Country Link
US (1) US20090215849A1 (fr)
EP (1) EP1855650B1 (fr)
JP (1) JP2008531517A (fr)
KR (1) KR20070112139A (fr)
CN (1) CN101128185A (fr)
AR (1) AR054228A1 (fr)
AU (1) AU2006218043B2 (fr)
BR (1) BRPI0608044A2 (fr)
CA (1) CA2598031A1 (fr)
DK (1) DK1855650T3 (fr)
ES (1) ES2400502T3 (fr)
FR (1) FR2882552B1 (fr)
MX (1) MX2007010179A (fr)
PL (1) PL1855650T3 (fr)
PT (1) PT1855650E (fr)
RU (1) RU2409346C2 (fr)
SI (1) SI1855650T1 (fr)
WO (1) WO2006089804A1 (fr)
ZA (1) ZA200707558B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107823123A (zh) 2011-06-28 2018-03-23 化学研究有限公司 高剂量粘膜粘附甲硝唑水基凝胶制剂及其治疗细菌性阴道病的用途
CN113476397B (zh) * 2021-07-12 2022-11-18 海南海神同洲制药有限公司 一种甲硝唑凝胶及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
WO1988006888A1 (fr) * 1987-03-20 1988-09-22 Curatek Pharmaceuticals, Inc. Nouvelles formations topiques a base de metronidazole et leurs utilisations therapeutiques
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
JP2533723B2 (ja) * 1992-12-28 1996-09-11 東興薬品工業株式会社 速乾性ゲルタイプ手指消毒剤
FR2700952B1 (fr) * 1993-01-29 1995-03-17 Oreal Nouvelles compositions cosmétiques ou dermopharmaceutiques sous forme de gels aqueux modifiés par addition de microsphères expansées.
FR2722098B1 (fr) * 1994-07-06 1996-08-23 Cird Galderma Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine
IN188720B (fr) * 1997-11-06 2002-11-02 Panacea Biotec Ltd
IL138889A0 (en) * 1998-04-17 2001-11-25 Bertek Pharm Inc Topical formulations for the treatment of nail fungal diseases
US7074832B2 (en) * 2001-09-24 2006-07-11 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
US7368122B1 (en) * 2002-03-08 2008-05-06 Dow Pharmaceutical Sciences Skin cream
US6846837B2 (en) * 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails
PE20040321A1 (es) * 2002-08-22 2004-07-15 Novartis Consumer Health Sa Composicion topica que comprende diclofenaco
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions

Also Published As

Publication number Publication date
AU2006218043B2 (en) 2012-02-02
WO2006089804A1 (fr) 2006-08-31
MX2007010179A (es) 2007-09-18
CN101128185A (zh) 2008-02-20
EP1855650B1 (fr) 2012-12-05
JP2008531517A (ja) 2008-08-14
FR2882552A1 (fr) 2006-09-01
ES2400502T3 (es) 2013-04-10
CA2598031A1 (fr) 2006-08-31
SI1855650T1 (sl) 2013-05-31
AU2006218043A1 (en) 2006-08-31
RU2007135364A (ru) 2009-03-27
KR20070112139A (ko) 2007-11-22
ZA200707558B (en) 2008-10-29
BRPI0608044A2 (pt) 2009-11-03
DK1855650T3 (da) 2013-02-25
PL1855650T3 (pl) 2013-04-30
PT1855650E (pt) 2013-02-28
US20090215849A1 (en) 2009-08-27
RU2409346C2 (ru) 2011-01-20
AR054228A1 (es) 2007-06-13
EP1855650A1 (fr) 2007-11-21

Similar Documents

Publication Publication Date Title
CY2017048I1 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
EG26976A (en) Amide derivatives, process for production of the same, and method for application thereof as insecticide
MA28802B1 (fr) Utilisations therapeutiques d'inhibiteurs de rtp801
CY2014011I2 (el) Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης
ATE384696T1 (de) Mandelsäure derivate
DK1893649T3 (da) Fremgangsmåde til forstærkning af opioide analgetikas virkninger på smerte
ATE416171T1 (de) 2-hydroxy-3-heteroarylindole derivate als gsk3 inhibitoren
DE602005011285D1 (de) Formmasse von polymer
IS2939B (is) Pýrósóló-kínasólín afleiður, aðferð við framleiðslu þeirra og notkun sem kínasa hindrar
ATE500227T1 (de) Amidderivate
MA28922B1 (fr) Nouveaux derives de phenylaminopyrimidine en tant qu'inhibiteurs de bcr-abl kinase
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
IS8242A (is) Nikótínamíð afleiður nytsamlegar sem PDE4 hindrar
DK1601359T3 (da) Væskeformige, farmaceutiske formuleringer af palonosetron
NO20052262D0 (no) Fremgangsmate til fremstilling av 4-substituerte 2,2,6,6-tetrametyl-piperidin-N-oksy- og 2,2,6,6-tetrametyl-piperidin-N-hydroksy-forbindelser
CR8618A (es) Nuevos derivados de bencil (dieno)-lactamas
ATE384530T1 (de) 4-aminochinolin-3-carbonsäureamid-derivate als pde4-hemmer
DE60335075D1 (de) Flüssigkeitszerstäuber
IS8366A (is) Lyfjablanda sem felur í sér pýrimídín-A-ónafleiðuhjúpaða með sýrufjölliðu
IL179974A0 (en) Substituted tetrahydroiso quinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drugs
NO20084860L (no) Stabile farmasøytiske preparater av 2-aza-bisyklo-[3,3,0]-oktan-3-karboksylsyrederivater
DE602004009733D1 (de) Dynamisches Ratenteilungsverfahren
FR2882552B1 (fr) Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation
HUP0401525A2 (en) Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them
DK1692137T3 (da) Fremgangsmåde til fremstilling af tubulinininhibitorer

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

ST Notification of lapse

Effective date: 20201006